ASX Announcements
|
-
26-Sep-2023
Investor Presentation Correction
Investor Presentation Correction
-
26-Sep-2023
Investor Presentation Correction
Investor Presentation Correction
-
26-Sep-2023
Cyclopharm Investor Update
Cyclopharm Investor Update
-
12-Sep-2023
Application for quotation of securities - CYC
Application for quotation of securities - CYC
-
25-Aug-2023
Litigation Update and Receipt of Settlement Payment
Litigation Update and Receipt of Settlement Payment
-
22-Aug-2023
Dividend/Distribution - CYC
Dividend/Distribution - CYC
-
22-Aug-2023
Half Year Accounts
Half Year Accounts
-
9-Aug-2023
USFDA Approval Process Update
USFDA Approval Process Update
-
17-Jul-2023
Cyclopharm 2023 Half Year Accounts Update - Record Revenues
Cyclopharm 2023 Half Year Accounts Update - Record Revenues
-
16-May-2023
Notification of buy-back - CYC
Notification of buy-back - CYC
-
16-May-2023
Results of Meeting
Results of Meeting
-
16-May-2023
Managing Director's Address to Shareholders
Managing Director's Address to Shareholders
|